Repression of thePDCD2gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas
- 1 May 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (18), 7449-7454
- https://doi.org/10.1073/pnas.0701770104
Abstract
The human BCL6 gene on chromosome 3 band q27, which encodes a transcriptional repressor, is implicated in the pathogenesis of human lymphomas, especially the diffuse large B-cell type. We previously identified the human PDCD2 (programmed cell death-2) gene as a target of BCL6 repression. PDCD2 encodes a protein that is expressed in many human tissues, including lymphocytes, and is known to interact with corepressor complexes. We now show that BCL6 can bind directly to the PDCD2 promoter, repressing its transcription. Knockdown of endogenous BCL6 in a human B cell lymphoma line by introduction of small interfering RNA duplexes increases PDCD2 protein expression. Furthermore, there is an inverse relationship between the expression levels of the BCL6 and PDCD2 proteins in the lymphoid tissues of mice overexpressing human BCL6 (high BCL6 levels, minimal PDCD2) and controls (minimal BCL6, high PDCD2) as well as in tissues examined from some human B and T cell lymphomas. These data confirm PDCD2 as a target of BCL6 and support the concept that repression of PDCD2 by BCL6 is likely important in the pathogenesis of certain human lymphomas.Keywords
This publication has 39 references indexed in Scilit:
- BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cellsNature Immunology, 2005
- Proteomics profiling of nuclear proteins for kidney fibroblasts suggests hypoxia, meiosis, and cancer may meet in the nucleusProteomics, 2005
- The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cellsNature, 2004
- Identification of candidate tumor‐suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasmsGenes, Chromosomes and Cancer, 2003
- PDCD2 is a negative regulator of HCF-1 (C1)Oncogene, 2002
- Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZFOncogene, 2000
- Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6Journal of Biological Chemistry, 1998
- Cloning of Mouse RP-8 cDNA and Its Expression During Apoptosis of Lymphoid and Myeloid CellsDNA and Cell Biology, 1995
- Recognition DNA Sequence of a Novel Putative Transcription Factor, BCL6Biochemical and Biophysical Research Communications, 1994
- Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell LymphomaScience, 1993